KBC Group NV Acquires 39 Shares of Chemed Co. (NYSE:CHE)

KBC Group NV grew its stake in Chemed Co. (NYSE:CHE) by 11.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 378 shares of the company’s stock after purchasing an additional 39 shares during the quarter. KBC Group NV’s holdings in Chemed were worth $227,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. GAMMA Investing LLC boosted its position in shares of Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after purchasing an additional 22 shares in the last quarter. American National Bank & Trust bought a new position in Chemed during the third quarter worth about $61,000. EntryPoint Capital LLC grew its stake in Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after acquiring an additional 18 shares during the period. Mather Group LLC. raised its position in shares of Chemed by 60.5% during the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after purchasing an additional 69 shares during the period. Finally, Quarry LP lifted its holdings in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Down 1.3 %

NYSE:CHE opened at $547.46 on Wednesday. Chemed Co. has a twelve month low of $523.33 and a twelve month high of $654.62. The company has a market cap of $8.24 billion, a P/E ratio of 27.66, a price-to-earnings-growth ratio of 2.37 and a beta of 0.46. The business has a 50 day moving average price of $579.53 and a two-hundred day moving average price of $565.25.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. During the same period last year, the business posted $5.32 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. As a group, analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be paid a $0.50 dividend. The ex-dividend date is Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.37%. Chemed’s dividend payout ratio is 10.11%.

Analyst Ratings Changes

Separately, Royal Bank of Canada cut their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at $62,117,555.35. This trade represents a 1.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 11.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,113 shares of company stock valued at $2,411,905 in the last 90 days. 3.32% of the stock is currently owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.